![Ronald Crystal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Crystal
Oprichter bij
Xylocor Therapeutics, Inc.
Profiel
Ronald G.
Crystal is the founder of GenVec, Inc. (1992), Xylocor Therapeutics, Inc. (2013), and Lexeo Therapeutics, Inc. (2017).
At Xylocor Therapeutics, Inc., he holds the title of Director.
Dr. Crystal is currently the Chairman of Genetic Medicine at Weill Cornell Medical College.
Crystal is also the founder of Annapurna Therapeutics SAS.
Actieve functies van Ronald Crystal
| Bedrijven | Functie | Begin |
|---|---|---|
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Oprichter | 01-01-2013 |
Eerdere bekende functies van Ronald Crystal
| Bedrijven | Functie | Einde |
|---|---|---|
| GENVEC INC | Oprichter | - |
| LEXEO THERAPEUTICS, INC. | Oprichter | - |
Annapurna Therapeutics SAS
 Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
82
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annapurna Therapeutics SAS
Annapurna Therapeutics SAS BiotechnologyHealth Technology Operates as a gene therapy company | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
